Indications |
Oral Cerebrovascular disorders, Peripheral vascular disease Adult: Initial: Up to 2 g daily. Maintenance: 800-1200 mg daily. Max Dosage: 2 g daily in divided doses. |
Contraindications |
Acute phase of cerebrovascular accidents. |
Warnings / Precautions |
Severe obliterative coronary artery disease; cerebrovascular disease. |
Adverse Reactions |
Flushes, GI upset, nausea, tingling, tachycardia, sweating, dizziness, headache. |
Mechanism of Actions |
Cyclandelate is a vasodilator more potent than papaverine. It has direct action on the plain muscle and there is no effect on the adrenergic tone. |
ATC Classification |
C04AX01 - cyclandelate ; Belongs to the class of other peripheral vasodilators. |
Available As |
|
Cyclandelate
Post Review about Cyclandelate Click here to cancel reply.
Cyclandelate Containing Brands
Cyclandelate is used in following diseases
Drug - Drug Interactions of Cyclandelate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.